Avnet
AVT
102.53
-3.84
-3.61%
Avnet
US · AVT
#1591 by market cap
Listed 1970
102.53
-3.84
-3.61%
Live - 5344 symbols - heartbeat 25s ago
· 2026-10-08 07:33
Pre-market
101.17
-1.33%
After-hours
102.44
-0.09%
- Market cap
- 8.43B
- P/E (TTM)i
- 25.57
- P/Bi
- 1.68
- EPSi
- 4.01
- Div yieldi
- 1.37%
- 52W posi
- 91%
Reader sentiment
Are you bullish or bearish on AVT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.23, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +24.47% YoY
Margins
- Gross margin
- 10.43%
- Operating margin
- 3.11%
- Net margin
- 1.21%
Key ratios & quality
- Enterprise valuei
- 11.54B
- Altman Z-Scorei
- 3.23
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.52B | 17.63B | 19.53B | 24.31B | 26.54B | 23.76B | 22.20B | 27.63B |
| Gross profit | 2.49B | 2.06B | 2.24B | 2.97B | 3.18B | 2.77B | 2.38B | 2.88B |
| Selling & admin expenses | 1.87B | 1.84B | 1.87B | 1.99B | 1.97B | 1.87B | 1.76B | 2.02B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 611.45M | 221.33M | 365.80M | 970.54M | 1.21B | 896.92M | 622.57M | 859.49M |
| Pretax profit | 236.60M | -129.59M | 172.93M | 833.33M | 982.88M | 632.26M | 250.57M | 467.44M |
| Tax | 60.26M | -98.50M | -20.19M | 140.96M | 212.05M | 133.56M | 10.35M | 133.05M |
| Net profit | 176.34M | -31.08M | 193.11M | 692.38M | 770.83M | 498.70M | 240.22M | 334.39M |
| Basic EPS | 2 | 0 | 2 | 7 | 8 | 6 | 3 | 4 |
| Diluted EPS | 1.59 | -0.31 | 1.93 | 6.94 | 8.26 | 5.43 | 2.75 | 4.01 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.32B | 5.62B | 5.90B | 6.32B | 7.12B | 8.30B |
| Gross profit | 587.85M | 593.69M | 614.77M | 663.04M | 739.06M | 865.03M |
| Selling & admin expenses | 435.49M | 451.17M | 464.44M | 491.67M | 518.79M | 547.51M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 152.36M | 142.51M | 150.32M | 171.37M | 220.27M | 317.53M |
| Pretax profit | 78.14M | 7.40M | 76.80M | 89.91M | 140.57M | 160.16M |
| Tax | -9.78M | 1.32M | 25.06M | 28.17M | 46.24M | 33.58M |
| Net profit | 87.92M | 6.09M | 51.75M | 61.73M | 94.33M | 126.58M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 2 |
| Diluted EPS | 1.01 | 0.07 | 0.61 | 0.75 | 1.14 | 1.49 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 6.88B | 6.33B | 7.16B | 8.88B | 10.75B | 10.37B | 10.02B | 13.33B |
| Cash & ST investments | 546.11M | 477.04M | 199.69M | 153.69M | 288.23M | 310.94M | 192.43M | 155.40M |
| Inventory | 3.01B | 2.73B | 3.24B | 4.24B | 5.47B | 5.47B | 5.24B | 6.07B |
| Total assets | 8.56B | 8.11B | 8.93B | 10.39B | 12.48B | 12.21B | 12.12B | 15.43B |
| Total current liabilities | 2.58B | 2.28B | 3.06B | 4.25B | 4.25B | 4.47B | 4.13B | 7.50B |
| Short-term debt | 300.54M | 53.36M | 81.42M | 228.95M | 122.43M | 546.70M | 143.53M | 789.84M |
| Long-term debt | 1.42B | 1.42B | 1.19B | 1.44B | 2.99B | 2.41B | 2.57B | 2.48B |
| Total liabilities | 4,424,083,000.00 | 4,378,799,000.00 | 4,841,238,000.00 | 6,195,772,000.00 | 7,725,490,000.00 | 7,283,643,000.00 | 7,107,058,000.00 | 10,402,890,000.00 |
| Total equity | 4.14B | 3.73B | 4.08B | 4.19B | 4.75B | 4.93B | 5.01B | 5.02B |
| Retained earnings | 2.77B | 2.42B | 2.52B | 2.92B | 3.38B | 3.60B | 3.43B | 3.51B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.80B | 10.02B | 10.33B | 11.02B | 11.38B | 13.33B |
| Cash & ST investments | 188.91M | 192.43M | 175.47M | 286.55M | 202.44M | 155.40M |
| Inventory | 5.27B | 5.24B | 5.42B | 5.29B | 5.46B | 6.07B |
| Total assets | 11.71B | 12.12B | 12.41B | 13.15B | 13.49B | 15.43B |
| Total current liabilities | 4.01B | 4.13B | 4.37B | 5.33B | 5.66B | 7.50B |
| Short-term debt | 200.08M | 143.53M | 244.14M | 516.35M | 520.87M | 789.84M |
| Long-term debt | 2.49B | 2.57B | 2.80B | 2.47B | 2.47B | 2.48B |
| Total liabilities | 6,827,363,000.00 | 7,107,058,000.00 | 7,566,256,000.00 | 8,215,241,000.00 | 8,535,957,000.00 | 10,402,890,000.00 |
| Total equity | 4.88B | 5.01B | 4.85B | 4.94B | 4.95B | 5.02B |
| Retained earnings | 3.50B | 3.43B | 3.32B | 3.35B | 3.42B | 3.51B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 534.77M | 730.18M | 90.95M | -219.31M | -713.70M | 689.98M | 724.50M | -280.93M |
| Depreciation & amortization | 180.84M | 242.90M | 188.70M | 155.21M | 143.01M | 140.50M | 125.20M | 134.75M |
| Free cash flow | 412.08M | 656.67M | 40.59M | -268.21M | -908.38M | 463.51M | 577.03M | -354.50M |
| Dividends paid | -87.16M | -83.98M | -84.31M | -98.49M | -106.33M | -111.96M | -113.31M | -114.36M |
| Stock buybacks / issuance | -568.71M | -237.84M | 0 | -184.38M | -221.73M | -162.72M | -303.49M | -138.31M |
| Ending cash balance | 546.11M | 477.04M | 199.69M | 153.69M | 288.23M | 310.94M | 192.43M | 155.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 140.88M | 139.48M | -144.58M | 208.24M | -53.84M | -290.74M |
| Depreciation & amortization | 29.01M | 31.93M | 30.77M | 33.39M | 33.36M | 37.22M |
| Free cash flow | 114.14M | 79.88M | -169.17M | 192.89M | -70.71M | -307.50M |
| Dividends paid | -28.23M | -27.67M | -28.46M | -28.47M | -28.71M | -28.72M |
| Stock buybacks / issuance | -101.29M | -50.00M | -138.31M | 0 | 0 | 0 |
| Ending cash balance | 188.91M | 192.43M | 175.47M | 286.55M | 202.44M | 155.40M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.00 | -0.79 | 4.94 | 16.73 | 17.24 | 10.31 | 4.83 | 6.67 |
| ROA %i | 1.94 | -0.37 | 2.27 | 7.17 | 6.74 | 4.04 | 1.97 | 2.43 |
| ROIC %i | 4.53 | 1.03 | 4.68 | 13.31 | 13.71 | 8.96 | 5.98 | 6.27 |
| 5-year avg ROE %i | 6.84 | 4.30 | 3.12 | 4.34 | 8.42 | 9.69 | 10.81 | 11.15 |
| EBIT margin %i | 1.93 | -0.03 | 1.34 | 3.84 | 4.65 | 3.85 | 2.24 | 2.60 |
| FCF / sales %i | 2.11 | 3.72 | 0.21 | -- | -- | 1.95 | 2.60 | -- |
| Current ratioi | 2.67 | 2.78 | 2.34 | 2.09 | 2.53 | 2.32 | 2.43 | 1.78 |
| Quick ratioi | 1.44 | 1.49 | 1.24 | 1.05 | 1.19 | 1.05 | 1.09 | 0.94 |
| Debt / assetsi | 20.09 | 21.37 | 16.95 | 17.96 | 26.46 | 25.61 | 23.75 | 22.53 |
| LT debt / equityi | 34.29 | 45.04 | 35.04 | 39.04 | 66.90 | 52.39 | 54.56 | 53.48 |
| Interest coveragei | 2.80 | -0.04 | 2.93 | 9.30 | 4.92 | 3.24 | 2.02 | 2.86 |
| Revenue CAGR (3Y) %i | 5.25 | 0.37 | 0.86 | 7.59 | 14.59 | 6.74 | -2.98 | 1.36 |
| Net income CAGR (3Y) %i | -29.65 | -- | -- | 57.76 | -- | 37.20 | -29.73 | -24.30 |
| FCF CAGR (3Y) %i | 67.98 | -- | -25.36 | -- | -- | 125.20 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.42 | 4.83 | 4.71 | 4.24 | 4.35 | 6.67 |
| ROA %i | 2.64 | 1.97 | 1.86 | 1.65 | 1.70 | 2.43 |
| ROIC %i | 6.90 | 5.98 | 5.60 | 5.15 | 4.78 | 6.27 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.69 | 2.24 | 2.20 | 2.13 | 2.23 | 2.60 |
| FCF / sales %i | 3.36 | 2.60 | 1.48 | 0.94 | 0.13 | -- |
| Current ratioi | 2.44 | 2.43 | 2.36 | 2.07 | 2.01 | 1.78 |
| Quick ratioi | 1.07 | 1.09 | 1.07 | 1.04 | 1.01 | 0.94 |
| Debt / assetsi | 24.18 | 23.75 | 25.77 | 24.08 | 23.52 | 22.53 |
| LT debt / equityi | 53.88 | 54.56 | 60.95 | 53.69 | 53.53 | 53.48 |
| Interest coveragei | 2.37 | 2.02 | 2.05 | 2.05 | 2.30 | 2.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Electronic Components is the largest reported line at 93.56% of revenue, across 2 reported segments.
- The next-largest line, Farnell, is a distant second at 6.44% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Electronic Components93.56%
Farnell6.44%
Region
Taiwan24.30%
United States22.18%
China (including Hong Kong)13.74%
EMEA12.38%
Germany9.83%
Singapore5.92%
Belgium5.74%
Asia4.64%
Americas1.27%
Quote time 2026-10-08 07:33:51 · For reference only, not investment advice and not tailored to your situation.